| Literature DB >> 29552003 |
Xiu P Chen1, Liaqat Ali1,2, Li-Yun Wu1, Can Liu1, Chen X Gang1, Qi F Huang1, Jing H Ruan1, Song Y Bao1, Yun P Rao1, DaoJin Yu1.
Abstract
In this study, microcosms were established to determine the effect ofEntities:
Keywords: Escherichia coli; antibiotic resistance; biofilm; biofilm-forming related genes; microcosm; nitrogen; no observed effect concentration (NOEC); phosphorus
Year: 2018 PMID: 29552003 PMCID: PMC5840168 DOI: 10.3389/fmicb.2018.00367
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Total N and total P treatments in the microcosm.
| Treatment groups | |||||
|---|---|---|---|---|---|
| Blank group | Lowest-dose group | Low-dose group | Medium-dose group | High-dose group | |
| Bucket number | a,b | 1, 2 | 3, 4 | 5, 6 | 7, 8 |
| TN (mg⋅L-1) | 0.65 | 1.5 | 2.5 | 3.5 | 4.5 |
| TP (mg⋅L-1) | 0.015 | 0.15 | 0.25 | 0.35 | 0.45 |
Standard of equivalent minimal inhibitory concentration (MIC) breakpoints for Escherichia coli.
| Antibiotic | MIC (μg⋅mL-1) | ||
|---|---|---|---|
| S | I | R | |
| Ampicillin | ≤8 | 16 | ≥32 |
| Cefazolin | ≤1 | 2 | ≥4 |
| Cefotaxime | ≤1 | 2 | ≥4 |
| Gentamicin | ≤4 | 8 | ≥16 |
| Ciprofloxacin | ≤1 | 2 | ≥4 |
| Tetracycline | ≤4 | 8 | ≥16 |
| Chloramphenicol | ≤8 | 16 | ≥32 |
List of primers used in this study.
| Gene | Length | Primer | Sequence | Reference |
|---|---|---|---|---|
| 116 bp | 5′-TGCCACACTGGTAGACGTTC-3′ | This study | ||
| 5′-TGATTGGTACGCCAGATGAG-3′ | ||||
| 105 bp | 5′-ACGCACACCACATACACGTT-3′ | This study | ||
| 5′-TCCAAACCTAACTCATCTGCAT-3′ | ||||
| 135 bp | 5′-ATCGTCTGGTGGCTGTCAA-3′ | This study | ||
| 5′-GTCCGCTATGTTTCGTCTCG-3′ | ||||
| 112 bp | 5′-GCTGGCTGTTATTGGTGTCG-3′ | This study | ||
| 5′-CAACTGGAGCAGGAACTTGG-3′ | ||||
| 120 bp | 5′-CTTCCTCGGTTGTCGTCTGT-3′ | This study | ||
| 5′-CTATCGCCGTTGAGTTTGGT-3′ | ||||
| 127 bp | 5′-GCGATGATTTCCAGTTTGTG-3′ | This study | ||
| 5′-ATTGGCACTGAACCAGGGTA-3′ | ||||
| 104 bp | 5′-GAAATGGGACGAAGTTGGTG-3′ | |||
| 5′-AACCACTTTCTTCGCACCAG-3′ |
Multidrug resistance (%) of Escherichia coli in different dose groups.
| Sampling time | Blank group | Lowest-dose group | Low-dose group | Medium-dose group | High-dose group |
|---|---|---|---|---|---|
| 0 day | 0% | 0% | 0% | 0% | 0% |
| 1 day | 0% | 60% | 0% | 50% | 57.14% |
| 8 days | 0% | 69.23% | 0% | 81.82% | 0% |
| 15 days | 0% | 0% | 50% | 50% | 0% |
| 22 days | 0% | 0% | 66.67% | 100% | 81.82% |
| 29 days | 0% | 60% | 57.14% | 100% | 100% |
| 36 days | 0% | 100% | 100% | 83.33% | 100% |
| 54 days | 0% | 100% | 100% | 100% | 100% |
| 85 days | 0% | 100% | 100% | 100% | 100% |